{"id":298814,"date":"2026-10-09T13:54:29","date_gmt":"2026-10-09T08:24:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=298814"},"modified":"2026-10-09T13:54:29","modified_gmt":"2026-10-09T08:24:29","slug":"torrent-pharmaceuticals-share-price-prediction-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/","title":{"rendered":"Torrent Pharmaceuticals Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>CMP Rs 4,634.90 (9 Oct 2026). 52W range Rs 3,480.60 to Rs 5,250.00. PE 82.48. 2027 base Rs 5,140, bull Rs 5,246.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Torrent Pharmaceuticals share price forecast for 2027 centres on a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246, against a current price of Rs 4,634.90. These targets scale today&#8217;s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 10.9% upside from today&#8217;s price. The daily technical setup reads bearish.<\/p>\n<\/p><\/div>\n<p>Torrent Pharmaceuticals share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 4,634.90 on NSE as of 9 October 2026, 11.7% below its 52-week high of Rs 5,250.00, after the company reported net profit of Rs 2,138.18 crore for FY26.<\/p>\n<p>This Torrent Pharmaceuticals stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=share-price-prediction-2027\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Torrent_Pharmaceuticals_Share_Price_Today_and_Key_Data\" title=\"Torrent Pharmaceuticals Share Price Today and Key Data\">Torrent Pharmaceuticals Share Price Today and Key Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#What_Is_the_Torrent_Pharmaceuticals_Share_Price_Prediction_for_2027\" title=\"What Is the Torrent Pharmaceuticals Share Price Prediction for 2027?\">What Is the Torrent Pharmaceuticals Share Price Prediction for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Torrent_Pharmaceuticals_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\" title=\"Torrent Pharmaceuticals Share Price Forecast: What Has to Go Right by 2027\">Torrent Pharmaceuticals Share Price Forecast: What Has to Go Right by 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Conservative_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5034\" title=\"Conservative Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,034\">Conservative Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,034<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Base_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5140\" title=\"Base Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,140\">Base Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,140<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Bull_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5246\" title=\"Bull Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,246\">Bull Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,246<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Torrent_Pharmaceuticals_Financial_Performance_Revenue_Profit_and_Margins\" title=\"Torrent Pharmaceuticals Financial Performance: Revenue, Profit and Margins\">Torrent Pharmaceuticals Financial Performance: Revenue, Profit and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Is_Torrent_Pharmaceuticals_Overvalued_or_Undervalued_Right_Now\" title=\"Is Torrent Pharmaceuticals Overvalued or Undervalued Right Now?\">Is Torrent Pharmaceuticals Overvalued or Undervalued Right Now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Torrent_Pharmaceuticals_Stock_Analysis_Technical_Outlook\" title=\"Torrent Pharmaceuticals Stock Analysis: Technical Outlook\">Torrent Pharmaceuticals Stock Analysis: Technical Outlook<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Torrent_Pharmaceuticals_Shareholding_Pattern\" title=\"Torrent Pharmaceuticals Shareholding Pattern\">Torrent Pharmaceuticals Shareholding Pattern<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Key_Risks_to_the_Torrent_Pharmaceuticals_Share_Price_Target_for_2027\" title=\"Key Risks to the Torrent Pharmaceuticals Share Price Target for 2027\">Key Risks to the Torrent Pharmaceuticals Share Price Target for 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Earnings_and_Margin_Risk\" title=\"Earnings and Margin Risk\">Earnings and Margin Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Valuation_Risk\" title=\"Valuation Risk\">Valuation Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Size_and_Liquidity_Risk\" title=\"Size and Liquidity Risk\">Size and Liquidity Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Balance_Sheet_Risk\" title=\"Balance Sheet Risk\">Balance Sheet Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Technical_Risk\" title=\"Technical Risk\">Technical Risk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Frequently_Asked_Questions_on_Torrent_Pharmaceuticals_Share_Price_Prediction_2027\" title=\"Frequently Asked Questions on Torrent Pharmaceuticals Share Price Prediction 2027\">Frequently Asked Questions on Torrent Pharmaceuticals Share Price Prediction 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#What_is_the_Torrent_Pharmaceuticals_share_price_target_for_2027\" title=\"What is the Torrent Pharmaceuticals share price target for 2027?\">What is the Torrent Pharmaceuticals share price target for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#What_is_the_Torrent_Pharmaceuticals_share_price_today\" title=\"What is the Torrent Pharmaceuticals share price today?\">What is the Torrent Pharmaceuticals share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Is_Torrent_Pharmaceuticals_a_good_stock_to_buy_for_2027\" title=\"Is Torrent Pharmaceuticals a good stock to buy for 2027?\">Is Torrent Pharmaceuticals a good stock to buy for 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#Can_Torrent_Pharmaceuticals_stock_reach_Rs_5246_in_2027\" title=\"Can Torrent Pharmaceuticals stock reach Rs 5,246 in 2027?\">Can Torrent Pharmaceuticals stock reach Rs 5,246 in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#What_are_the_support_and_resistance_levels_for_Torrent_Pharmaceuticals\" title=\"What are the support and resistance levels for Torrent Pharmaceuticals?\">What are the support and resistance levels for Torrent Pharmaceuticals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#What_are_the_main_risks_for_Torrent_Pharmaceuticals_stock_in_2027\" title=\"What are the main risks for Torrent Pharmaceuticals stock in 2027?\">What are the main risks for Torrent Pharmaceuticals stock in 2027?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/torrent-pharmaceuticals-share-price-prediction-2027\/#How_is_the_Torrent_Pharmaceuticals_target_price_for_2027_calculated\" title=\"How is the Torrent Pharmaceuticals target price for 2027 calculated?\">How is the Torrent Pharmaceuticals target price for 2027 calculated?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Share_Price_Today_and_Key_Data\"><\/span><strong>Torrent Pharmaceuticals Share Price Today and Key Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Torrent Pharmaceuticals share price today is Rs 4,634.90 on NSE, up 0.39% on the day. The market capitalisation stands at Rs 1,77,822 crore. Over the past year the price has risen 30.5% from Rs 3,550.50. Every Torrent Pharmaceuticals stock forecast figure below starts from this price.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Metric<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Company<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Torrent Pharmaceuticals (TORNTPHARM)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Current Price<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 4,634.90<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week High<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 5,250.00 (3 August 2026)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">52-Week Low<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 3,480.60 (14 October 2025)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Market Cap<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 1,77,822 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PE Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">82.48<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Industry PE<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">37.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">PB Ratio<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">21.15<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 56.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Return on Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">25.49%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1.79<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">0.72%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Book Value per Share<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 221.09<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Is_the_Torrent_Pharmaceuticals_Share_Price_Prediction_for_2027\"><\/span><strong>What Is the Torrent Pharmaceuticals Share Price Prediction for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Torrent Pharmaceuticals share price prediction for 2027 is a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246. Against Rs 4,634.90, these imply 8.6% upside, 10.9% upside and 13.2% upside. They are model scenarios built from reported EPS growth, not broker targets.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Scenario<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Growth Basis<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS Estimate<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">PE Multiple<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Implied Value<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Upside vs Current Price<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Conservative Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Lower of FY26 growth (13.2%) and 4-year CAGR (8.6%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 61.56 (+8.6%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 5,034<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+8.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Base Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Average of the two<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 62.86 (+10.9%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 5,140<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+10.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bull Case<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Higher of the two<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 64.16 (+13.2%)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Unchanged from today (price to EPS ratio kept constant)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 5,246<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">+13.2%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Each target takes today&#8217;s price of Rs 4,634.90 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Torrent Pharmaceuticals target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Share_Price_Forecast_What_Has_to_Go_Right_by_2027\"><\/span><strong>Torrent Pharmaceuticals Share Price Forecast: What Has to Go Right by 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Each Torrent Pharmaceuticals target price below depends on a specific EPS outcome, and the text states that outcome next to the number.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Conservative_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5034\"><\/span><strong>Conservative Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,034<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 5,034 needs EPS to rise 8.6% to Rs 61.56 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 8.6%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Base_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5140\"><\/span><strong>Base Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,140<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 5,140 needs EPS to rise 10.9% to Rs 62.86, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 3.3% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_for_the_Torrent_Pharmaceuticals_Share_Price_Target_Rs_5246\"><\/span><strong>Bull Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,246<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Reaching Rs 5,246 needs EPS to rise 13.2% to Rs 64.16 with the PE multiple held at today&#8217;s level. That sits inside the 52-week range of Rs 3,480.60 to Rs 5,250.00. A daily close above the nearest resistance level of Rs 4,909.63 (50-day SMA) would be the first technical confirmation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Financial_Performance_Revenue_Profit_and_Margins\"><\/span><strong>Torrent Pharmaceuticals Financial Performance: Revenue, Profit and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Torrent Pharmaceuticals earned net profit of Rs 2,138.18 crore on revenue of Rs 13,886.15 crore in FY26, with profit up 11.9% and revenue up 20.3% compared with FY25. Diluted EPS was Rs 63.92 against Rs 56.47 a year earlier, and that earnings base anchors the Torrent Pharmaceuticals share price forecast.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Year<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">EPS (Rs)<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Operating Margin<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY22<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">8,704.60<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">777.18<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">45.93<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">30.77%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">8.93%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY23<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">9,665.29<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,245.23<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">36.79<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">30.01%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">12.88%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY24<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">10,785.75<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,656.38<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">48.94<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">32.76%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">15.36%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY25<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">11,539.36<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">1,911.25<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">56.47<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">32.30%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">16.56%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">FY26<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">13,886.15<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">2,138.18<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">63.92<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">22.70%<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">15.40%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 4,909 crore against Rs 3,141 crore a year earlier (+56.3%), and the bottom line was a net profit of Rs 566 crore against a net profit of Rs 548 crore (+3.3%). Operating margin was 33.73% versus 31.81% in the year-ago quarter. Cash flow from operations was Rs 3,022.71 crore in FY26 against Rs 2,585.11 crore in FY25. Together these figures set the earnings base for the Torrent Pharmaceuticals share price prediction.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live Torrent Pharmaceuticals fundamentals<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Torrent_Pharmaceuticals_Overvalued_or_Undervalued_Right_Now\"><\/span><strong>Is Torrent Pharmaceuticals Overvalued or Undervalued Right Now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Torrent Pharmaceuticals trades at a PE of 82.48 against an industry PE of 37.59, which places the stock at a 119.4% premium to the industry average. The price-to-book ratio is 21.15 on a book value of Rs 221.09 per share. Return on equity of 25.49% means the company earns Rs 25.49 of profit for every Rs 100 of shareholder equity.<\/p>\n<p>Debt to equity is 1.79, so borrowings equal about 179% of shareholder equity. The company declared a dividend of Rs 38.00 per share for FY26, a yield of 0.72% at the current price. This valuation context frames the Torrent Pharmaceuticals stock price prediction for 2027 without relying on any outside forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Stock_Analysis_Technical_Outlook\"><\/span><strong>Torrent Pharmaceuticals Stock Analysis: Technical Outlook<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Torrent Pharmaceuticals stock trades below its 50-day SMA of Rs 4,909.63 and above its 200-day EMA of Rs 4,493.11, and the combined daily indicators read bearish. The 52-week high of Rs 5,250.00 was set on 3 August 2026, while the 52-week low of Rs 3,480.60 came on 14 October 2025.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Indicator<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Reading<\/th>\n<th style=\"border:1px solid #cccccc;padding:8px;text-align:left;background:#F2F2F2;\">Signal<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">RSI (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">36.92<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Weak momentum<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">MACD (12,26,9)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">-64.89 vs signal -35.81<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">ADX (14)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">28.85<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Established trend<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Supertrend (10,3)<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below Rs 4,950.15<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Bearish<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">50-day SMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 4,909.63<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price below<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">200-day EMA<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Rs 4,493.11<\/td>\n<td style=\"border:1px solid #cccccc;padding:8px;text-align:left;\">Price above<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The nearest support level sits at Rs 4,493.11 (200-day EMA) and Rs 3,480.60 (52-week low). The nearest resistance level sits at Rs 4,909.63 (50-day SMA) and Rs 4,950.15 (Supertrend). A sustained move above the nearest resistance would support the Torrent Pharmaceuticals share price prediction 2027 base case, and this Torrent Pharmaceuticals stock analysis uses daily candles only. Chart signals add context to the Torrent Pharmaceuticals share price target without changing the earnings maths.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Torrent_Pharmaceuticals_Shareholding_Pattern\"><\/span><strong>Torrent Pharmaceuticals Shareholding Pattern<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Promoters hold 60.78% of Torrent Pharmaceuticals as of Jul 2026, down from 68.31% in Sep 2025 across the last 5 quarters. FII holding is 17.97% (up from 15.92% in Sep 2025) and DII holding is 12.87% (up from 9.28% in Sep 2025), which puts combined institutional holding at 30.84%. Public shareholders own 8.38%. Shareholding data is one input for any Torrent Pharmaceuticals stock forecast.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_the_Torrent_Pharmaceuticals_Share_Price_Target_for_2027\"><\/span><strong>Key Risks to the Torrent Pharmaceuticals Share Price Target for 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Earnings_and_Margin_Risk\"><\/span><strong>Earnings and Margin Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Operating margin has ranged from 22.70% to 32.76% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Torrent Pharmaceuticals stock forecast. Revenue was up 20.3% in FY26, and slower revenue growth would weigh on the profit path.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Valuation_Risk\"><\/span><strong>Valuation Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The PE of 82.48 is 119.4% above the industry PE of 37.59. Every target here holds the multiple constant, so a narrowing of that premium would leave returns below these targets even if earnings grow as assumed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Size_and_Liquidity_Risk\"><\/span><strong>Size and Liquidity Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Market capitalisation stands at Rs 1,77,822 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Torrent Pharmaceuticals stock price target.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Balance_Sheet_Risk\"><\/span><strong>Balance Sheet Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Debt to equity of 1.79 means borrowings stand at about 179% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Torrent Pharmaceuticals share price forecast.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Technical_Risk\"><\/span><strong>Technical Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 4,493.11 (200-day EMA) would weaken the setup further.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This Torrent Pharmaceuticals stock analysis puts the share price target range for 2027 at Rs 5,034 to Rs 5,246, with a base case of Rs 5,140 against Rs 4,634.90 today. The inputs are a PE of 82.48 that sits at a 119.4% premium to the industry average, EPS growth of 13.2% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Torrent Pharmaceuticals live price and get daily stock recommendations.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Torrent_Pharmaceuticals_Share_Price_Prediction_2027\"><\/span><strong>Frequently Asked Questions on Torrent Pharmaceuticals Share Price Prediction 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Torrent_Pharmaceuticals_share_price_target_for_2027\"><\/span><strong>What is the Torrent Pharmaceuticals share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Torrent Pharmaceuticals share price forecast for 2027 has a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Torrent_Pharmaceuticals_share_price_today\"><\/span><strong>What is the Torrent Pharmaceuticals share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Torrent Pharmaceuticals trades at Rs 4,634.90 on NSE as of 9 October 2026, up 0.39% on the day. The 52-week range is Rs 3,480.60 to Rs 5,250.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Torrent_Pharmaceuticals_a_good_stock_to_buy_for_2027\"><\/span><strong>Is Torrent Pharmaceuticals a good stock to buy for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The data points in different directions: the PE of 82.48 is at a 119.4% premium to the industry average, EPS grew 13.2% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Torrent_Pharmaceuticals_stock_reach_Rs_5246_in_2027\"><\/span><strong>Can Torrent Pharmaceuticals stock reach Rs 5,246 in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Reaching Rs 5,246 needs EPS to rise 13.2% from Rs 56.68 with the PE multiple held at today&#8217;s level, plus a daily close above Rs 4,909.63 (50-day SMA). This is a scenario, not a guarantee.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_support_and_resistance_levels_for_Torrent_Pharmaceuticals\"><\/span><strong>What are the support and resistance levels for Torrent Pharmaceuticals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The nearest support levels are Rs 4,493.11 (200-day EMA) and Rs 3,480.60 (52-week low), and the nearest resistance levels are Rs 4,909.63 (50-day SMA) and Rs 4,950.15 (Supertrend).<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_risks_for_Torrent_Pharmaceuticals_stock_in_2027\"><\/span><strong>What are the main risks for Torrent Pharmaceuticals stock in 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks to the Torrent Pharmaceuticals share price forecast are a fall in operating margin from the 22.70% to 32.76% range seen since FY22, slower revenue growth after FY26 revenue was up 20.3%, and thin trading volumes. Debt to equity of 1.79 adds balance sheet sensitivity.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_the_Torrent_Pharmaceuticals_target_price_for_2027_calculated\"><\/span><strong>How is the Torrent Pharmaceuticals target price for 2027 calculated?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 8.6% growth, the base case 10.9% and the bull case 13.2%, all drawn from the company&#8217;s reported FY26 and 4-year EPS growth.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Torrent Pharmaceuticals share price target for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Torrent Pharmaceuticals share price forecast for 2027 has a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.\"}},{\"@type\":\"Question\",\"name\":\"What is the Torrent Pharmaceuticals share price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Torrent Pharmaceuticals trades at Rs 4,634.90 on NSE as of 9 October 2026, up 0.39% on the day. The 52-week range is Rs 3,480.60 to Rs 5,250.00.\"}},{\"@type\":\"Question\",\"name\":\"Is Torrent Pharmaceuticals a good stock to buy for 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The data points in different directions: the PE of 82.48 is at a 119.4% premium to the industry average, EPS grew 13.2% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"Can Torrent Pharmaceuticals stock reach Rs 5,246 in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Reaching Rs 5,246 needs EPS to rise 13.2% from Rs 56.68 with the PE multiple held at today's level, plus a daily close above Rs 4,909.63 (50-day SMA). This is a scenario, not a guarantee.\"}},{\"@type\":\"Question\",\"name\":\"What are the support and resistance levels for Torrent Pharmaceuticals?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The nearest support levels are Rs 4,493.11 (200-day EMA) and Rs 3,480.60 (52-week low), and the nearest resistance levels are Rs 4,909.63 (50-day SMA) and Rs 4,950.15 (Supertrend).\"}},{\"@type\":\"Question\",\"name\":\"What are the main risks for Torrent Pharmaceuticals stock in 2027?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks to the Torrent Pharmaceuticals share price forecast are a fall in operating margin from the 22.70% to 32.76% range seen since FY22, slower revenue growth after FY26 revenue was up 20.3%, and thin trading volumes. Debt to equity of 1.79 adds balance sheet sensitivity.\"}},{\"@type\":\"Question\",\"name\":\"How is the Torrent Pharmaceuticals target price for 2027 calculated?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 8.6% growth, the base case 10.9% and the bull case 13.2%, all drawn from the company's reported FY26 and 4-year EPS growth.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Torrent Pharmaceuticals share price prediction 2027: base case Rs 5,140, bull case Rs 5,246 and a conservative case of Rs 5,034, built from reported EPS growth, valuation, technical levels and shareholding data.<\/p>\n","protected":false},"author":38,"featured_media":298812,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[1007,1019],"class_list":["post-298814","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-pharma-stocks","tag-stock-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["298812"],"rank_math_title":["Torrent Pharmaceuticals Share Price Prediction 2027"],"rank_math_description":["Torrent Pharmaceuticals share price prediction 2027: conservative Rs 5,034, base Rs 5,140, bull Rs 5,246 vs current Rs 4,635. Valuation, financials, technicals and risks."],"rank_math_focus_keyword":["Torrent Pharmaceuticals share price prediction 2027 | Density Target: 1.2-1.5%"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/torrent-pharmaceuticals-share-price-prediction-2027-scenario-targets-valuation.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/38"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=298814"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298814\/revisions"}],"predecessor-version":[{"id":298816,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/298814\/revisions\/298816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/298812"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=298814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=298814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=298814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}